期刊文献+

NF-κB/p65和VEGF在卵巢上皮性肿瘤的表达及临床意义

Expression and clinical significance of NF-κB/p65 and VEGF in ovarian epithelial tumor.
下载PDF
导出
摘要 目的:研究NF-κB/p65和VEGF在卵巢上皮性肿瘤的表达及临床意义。方法:应用免疫组化SP法,检测NF-κB/p65和VEGF在10例正常卵巢组织,20例卵巢良性上皮性肿瘤,10例卵巢交界性上皮性肿瘤,60例卵巢上皮性癌中的表达。结果:NF-κB/p65和VEGF在卵巢上皮性癌中的表达率均高于卵巢交界性上皮性肿瘤、卵巢良性上皮性肿瘤的表达率,差异有统计学意义(P<0.05)。卵巢上皮性癌中NF-κB/p65和VEGF的阳性表达率,中低分化组高于高分化组,有淋巴结转移组高于无淋巴结转移组,差异均有统计学意义(P<0.05);Ⅲ~Ⅳ期的表达率显著高于Ⅰ~Ⅱ期,差异有显著统计学意义(P<0.01)。卵巢上皮性癌患者腹水量>500m l组中VEGF表达率显著高于腹水量<500m l组(P<0.01),NF-κB/p65在腹水量>500m l组和腹水量≤500m l组中的表达率差异无统计学意义(P>0.05);VEGF与NF-κB/p65在卵巢肿瘤组织中的表达强度呈正相关(r=0.279,P<0.01)。结论:NF-κB/p65及VEGF与卵巢上皮性癌的发生发展有关,与卵巢上皮性癌病理分级、临床分期、淋巴结转移有关,VEGF与腹水形成有关;VEGF可作为判断预后的候选指标;NF-κB/p65对VEGF有调控作用。 Objective:To investigate the clinical significance and prognostic value of the expression of NF-κB/p65 and VEGF in ovarian epithelial tumors.Methods:The expression of NF-κB/p65 and VEGF in 60 cases of ovarian epithelial cancers,20 benign ovarian tumors,10 borderline epithelial tumors of the ovary and 10 normal controls were determined by using immunohistochemistry.Results:The positive expression of NF-κB/p65 and VEGF in ovarian epithelial cancers was significantly higher than that in ovarian epithelial borderline tumors and ovarian epithelial benign tumors(P0.05);the positive rate and overexpression of NF-κB/p65 and VEGF in moderately,poorly differentiated tissues,in lymphoid metastasis and in Ⅲ~Ⅳ stages were significantly higher than that in well differentiated tissues(P0.05),in unlymphoid metastasis ones(P0.05) and inⅠ~Ⅱ stages of ovarian epithelial cancers(P0.01),respectively.The positive expression rate of VEGF in volume of ascites more than 500ml group was significantly higher than that in less than 500ml group of ovarian epithelial cancers(P0.01);NF-κB/p65 expression had no significant difference between those two groups(P0.05).There was a positive correlation between VEGF and NF-κB/p65(r=0.279,P0.01).Conclusions:NF-κB/p65 and VEGF expression has relation with the development of ovarian epithelial cancer,pathological grades,clinical stage,and lymphoid metastasis.Under the regulation of NF-κB/p65,VEGF has also relation with the growth of ascites and maybe play an important role in prognosis indicator.
作者 苏悦 马志松
出处 《现代妇产科进展》 CSCD 北大核心 2011年第6期425-427,431,共4页 Progress in Obstetrics and Gynecology
关键词 卵巢上皮性肿瘤 核因子ΚB 血管内皮生长因子 Ovarian epithelial tumor NF-κB/p65 Vascular endothelial growth factor
  • 相关文献

参考文献10

  • 1Olivier S, Robe P, Bours V. Can NF-KappaB be a target for novel and efficient anti-cancer agents [ J ]. Biochem Pharmacol, 2006,72 ( 9 ) : 1054-1068.
  • 2许静,汪宏波,沈晓燕,张萍德,王泽华.VEGF和SDF-1/CXCR4在促进卵巢癌细胞侵袭与增殖中的相关作用[J].现代妇产科进展,2007,16(5):366-370. 被引量:10
  • 3Ahmed ME, Derek AM. Nuclear factor-KB and the hepatic inflammation-fibrosisi-cancer axis [ J ]. Hepatol, 2007,46 (2) :590-597.
  • 4Olivier S, Robe P, Bours V. Can NF-KappaB be a target for novel and efficient anti-cancer agents [ J ]. Biochem Pharmacol,2006,72 (9) : 1054-1068.
  • 5Karavasilis V, Malamou-Mitsi V, Briasoulis E, et al. Clini- copathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed byCD34 in patients with stage Ⅲ ovarian carcinoma[ J ]. Int J Gynecol Cancer,2006,16:241-246.
  • 6胡雪君,宋娜,刘云鹏,马艳菊,郝艳艳,康健.EGFR、VEGF和COX-2在非小细胞肺癌中的表达和意义[J].实用肿瘤杂志,2007,22(3):209-213. 被引量:19
  • 7Yabushita H, Shimazu M, Noguchi M, et al. Vascular endothelial growth factor activating matrix metalloproteinase in ascetic fluid during peritoneal dissemination of ovarian cancer[ J ]. Oncol Rep ,2003,10 ( 1 ) : 89-95.
  • 8Liao X, Siu MK, Au CW, et al. Aberrant activation of hedgehog signaling pathway in ovarian cancers:effect on prognosis, cell invasion and differentiation [ J ]. Carcinogenesis, 2009,30 : 131 -140.
  • 9Kuntzen C, Zazzeroni F, Pham CG,et al. A method for isolating prosurvival targets of NF-KappaB/Rel transcription factors [ J]. Methods Mol Bioi,2007,399:99-124.
  • 10Grosjean J, Kiriakidis S, Reilly K, et al. Vascular endothelial growth factor signaling in endothelial cell survival : a role for NF-KappaB [ J ]. Biochen Biophys Res Commun, 2006,340 : 984-994.

二级参考文献12

  • 1李芳,朱怀仕,韩志强,陈刚,高庆蕾,贾平,张阿丽,奚玲,徐茜,廖国宁,王世宣,卢运萍,马丁.趋化因子受体及配体在卵巢癌细胞迁移中的作用[J].癌症,2005,24(1):23-27. 被引量:20
  • 2Moran EM.Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risk[J].J Environ Pathol Toxicol Oncol,2002,21(2):193-220.
  • 3Pore N,Jiang Z,Gupta A,et al.EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-l-dependent mechanisms[J].Cancer Res,2006,66(6):3197-3204.
  • 4Ciardiello F,Troiani T,Bianco R,et al.Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways:a rational approach for multi-target anticancer therapy[J].Ann Oncol,2006,17(Suppl 7):109-114.
  • 5Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 6Atkins D,Reiffen KA,Tegtmeier CL,et al.Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues:variation in staining intensity due to choice of fixative and storage time of tissue sections[J].J Histochem Cytochem,2004,52(7):893-901.
  • 7Mineo TC,Ambrogi V,Baldi A,et al.Prognostic impact of VEGF,CD31,CD34,and CD105 expression and tumour vessel invasion after radical surgery for ⅠB-ⅡA non-small cell lung cancer[J].J Clin Pathol,2004,57(6):591-597.
  • 8Laga AC,Zander DS,Cagle PT.Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer[J].Arch Pathol Lab Med,2005,129(9):1113-1117.
  • 9Kuo CW,Chen YM,Chao JY,et al.Non-small cell lung cancer in very young and very old patients[J].Chest,2000,117(2):354-357.
  • 10Pfeiffer P,Nexo E,Bentzen SM,et al.Enzyme-linked immunosorbent assay of epidermal growth factor receptor in lung cancer:comparisons with immunohistochemistry,clinicopathological features and prognosis[J].Br J Cancer,1998,78(1):96-99.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部